Cardinal Health dividend yield – Cardinal Health Announces Cash Dividend of 0.4957

March 13, 2023

Dividends Yield

Cardinal Health ($NYSE:CAH) Inc. recently announced a cash dividend of 0.4957 on March 1 2023. CARDINAL HEALTH has consistently issued dividends per share of 1.98 USD in the past 3 years and is expected to maintain that level in the upcoming years. The expected dividend yields from 2021 to 2023 are 2.11%, 3.09%, and 3.72%, with an average dividend yield of 2.97%. This is a great opportunity for investors who are interested in dividend stocks.

CARDINAL HEALTH is an especially attractive option since the ex-dividend date is set for March 31 2023. With a consistent dividend yield and a steady track record, CARDINAL HEALTH is well positioned to maintain a strong dividend policy going forward.

Share Price

On the same day, stock of Cardinal Health opened at $75.4 and closed at $76.0, up by 0.4% from previous closing price of 75.7. Through this dividend, Cardinal Health Inc. has demonstrated its commitment to rewarding its shareholders with reliable dividend income. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cardinal Health. More…

    Total Revenues Net Income Net Margin
    193.01k -1.27k -0.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cardinal Health. More…

    Operations Investing Financing
    3.19k -405 -2.28k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cardinal Health. More…

    Total Assets Total Liabilities Book Value Per Share
    44.48k 46.69k -6.8
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cardinal Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    8.8% -3.0% -0.0%
    FCF Margin ROE ROA
    1.4% 2.5% -0.1%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we’ve conducted an analysis of CARDINAL HEALTH‘s financials. Our Risk Rating assigns a medium risk to the company on both financial and business aspects. Upon further inspection, we have identified one risk warning in the income sheet. To be able to check out this warning in more detail, we recommend that you register with GoodWhale.com. We understand that when it comes to investing, understanding the risks is of utmost importance. That’s why our Risk Rating is based on financial and business data, and we are committed to providing you with all the information you need to make the best investment decision for yourself. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis


  • Peers

    Its competitors are AmerisourceBergen Corp, McKesson Corp, and Sigma Healthcare Ltd.

    – AmerisourceBergen Corp ($NYSE:ABC)

    AmerisourceBergen Corp is a drug wholesaler that was founded in 1985. The company has a market cap of 32.4B as of 2022 and a return on equity of 417.0%. AmerisourceBergen Corp distributes prescription drugs and other healthcare products and services to healthcare providers and pharmaceutical companies. The company operates in two segments, Pharmaceutical Distribution and Other.

    – McKesson Corp ($NYSE:MCK)

    McKesson Corp is a healthcare services and information technology company. It has a market cap of 55.96B as of 2022 and a Return on Equity of -74.43%. The company provides a range of services and products to healthcare providers, payers, and consumers. These services and products include prescription drugs, medical supplies, and software and technology solutions.

    – Sigma Healthcare Ltd ($ASX:SIG)

    Sigma Healthcare Ltd is a pharmaceutical company with a market cap of 683.23M as of 2022 and a ROE of 0.46%. The company manufactures and distributes a range of prescription and over-the-counter medicines, medical devices, and other healthcare products.

    Summary

    Investing in Cardinal Health can provide investors with an attractive dividend yield of 2.97%, on average, over the next three years. The company has paid out dividends of 1.98 USD per share in the past three years, and it is expected to pay out dividend yields of 2.11%, 3.09%, and 3.72% in 2021, 2022, and 2023, respectively. Due to its consistent dividend payouts, Cardinal Health has become an attractive income investment option for investors who are looking for an investment with a steady return.

    In addition, the company’s stock price has been relatively stable over the past few years, making it an attractive option for those investors who are looking for a low-risk investment. As with any stock, it is important to thoroughly research the company and its performance before making any investment decisions.

    Recent Posts

    Leave a Comment